Reddigari S, Kaplan A P
Department of Medicine, State University of New York, Stony Brook 11794.
Blood. 1988 May;71(5):1334-40.
To study the digestion pattern of human high-molecular weight (mol wt) kininogen (HMWK) in plasma during contact activation we have prepared monoclonal antibodies (MoAbs) to the light-chain (LC) and the heavy-chain moiety of HMWK. One MoAb from each set was purified, and neither MoAb inhibited the clotting activity of HMWK. In enzyme-linked immunosorbent assay and immunoblotting experiments neither antibody bound to kininogen-deficient plasma. Digestion of purified HMWK with plasma kallikrein yielded, on reduced sodium dodecyl sulfate gels, two LC forms, at 62 and 49 kd, respectively. Digestion of HMWK with tissue kallikrein (TK) yielded mainly the 62-kd form. In immunoblot analyses of these digests, the anti-LC MoAb detected products at 62 and 49 kd respectively. With plasma kallikrein, the 62-kd species slowly shifted to 49 kd, and with TK, the 62-kd species accumulated with time. Anti-LC MoAb was also used as a probe in immunoblotting experiments to study the digestion pattern of HMWK in whole plasma activated with kaolin or dextran sulfate. In activated normal pooled plasma (NHP) and factor XI-deficient plasma, native HMWK (mol wt, 115 kd) was cleaved within five to ten minutes, and two LC forms at 62 and 49 kd were detected. In kaolin-activated prekallikrein (PK)-deficient plasma, the disappearance of the 115-kd form was relatively slow, and only the 62-kd form of LC was seen. HMWK was not cleaved when factor XII-deficient plasma was incubated with kaolin. LC-dependent coagulant activity paralleled the presence of LC bands seen in the immunoblots, and lower-mol wt fragments of LC were not identified. These data indicate that in activated NHP two forms of LC of HMWK (62 and 49 kd) are formed sequentially. Further, the LC-dependent coagulant activity remains detectable long enough to suggest that proteolytic inactivation of LC is too slow to be an important control mechanism.
为研究接触激活过程中人类高分子量(mol wt)激肽原(HMWK)在血浆中的消化模式,我们制备了针对HMWK轻链(LC)和重链部分的单克隆抗体(MoAbs)。从每组中纯化出一种MoAb,且两种MoAb均未抑制HMWK的凝血活性。在酶联免疫吸附测定和免疫印迹实验中,两种抗体均未与激肽原缺陷血浆结合。用血浆激肽释放酶消化纯化的HMWK,在还原十二烷基硫酸钠凝胶上产生两种LC形式,分别为62和49 kd。用组织激肽释放酶(TK)消化HMWK主要产生62-kd形式。在这些消化产物的免疫印迹分析中,抗LC MoAb分别检测到62和49 kd的产物。用血浆激肽释放酶时,62-kd物种缓慢转变为49 kd,而用TK时,62-kd物种随时间积累。抗LC MoAb还用作免疫印迹实验中的探针,以研究高岭土或硫酸葡聚糖激活的全血浆中HMWK的消化模式。在活化的正常混合血浆(NHP)和因子XI缺陷血浆中,天然HMWK(mol wt,115 kd)在五到十分钟内被切割,并检测到62和49 kd的两种LC形式。在高岭土激活的前激肽释放酶(PK)缺陷血浆中,115-kd形式的消失相对较慢,仅可见62-kd形式的LC。当因子XII缺陷血浆与高岭土孵育时,HMWK未被切割。LC依赖性凝血活性与免疫印迹中可见的LC条带的存在平行,且未鉴定出较低分子量的LC片段。这些数据表明,在活化的NHP中,HMWK的两种LC形式(62和49 kd)依次形成。此外,LC依赖性凝血活性在足够长的时间内仍可检测到,这表明LC的蛋白水解失活太慢,不足以成为重要的控制机制。